Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 30, 2017. The report serves to notify the SEC of the publication of the 2017 Notice of Annual General Meeting (AGM) and the Annual Summary 2016.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder communications rather than a financial results report.
Material Changes
No material financial changes or comparative period data are disclosed in this filing.
Guidance, Outlook, and Management Commentary
The Company announced that the 2017 Annual General Meeting will be held on Thursday, May 4, 2017, at 2:30 pm at The Queen Elizabeth II Centre in London. The 2017 AGM Notice and Annual Summary 2016 have been published on the Company's website and will be sent to shareholders who elected paper communications. These documents will also be submitted to the UK Listing Authority and made available for inspection via the Morningstar UK website.
Investor Verification Checklist
- Verify the date and location of the Annual General Meeting (May 4, 2017, London).
- Access the Annual Summary 2016 and Annual Report 2016 on the GSK investor website for detailed financial performance.
- Confirm the availability of the 2017 AGM Notice on the Morningstar UK website as required by UK Listing Rule 9.6.1.